JMCP Findings - Bridging the Gaps in Precision Oncology: Opportunities in Non-Small Cell Lung Cancer

Topic(s):

Market Insights , Cancer – Non-Small Cell Lung Cancer (NSCLC)

FINDINGS FROM THE AMCP MARKET INSIGHTS PROGRAM | July, 2023

Summary

Lung cancer is the most common cancer worldwide, with non-small cell lung cancer (NSCLC) accounting for approximately 85% of all lung cancers. The National Institutes of Health estimated that cancer care cost the US $208.9 billion in 2020, $23.8 billion of which was due to lung cancer. View the full fundings from the program on JMCP.

For more disease state research, view the Market Insights Program.